Purdue University College of Veterinary Medicine
University / teaching hospital
4 current cancer treatment or research opportunities
About Purdue comparative oncology
Purdue's Comparative Oncology Program connects the veterinary teaching hospital with cancer scientists across the university. Its teams have studied immune treatments, cancer vaccines and focused ultrasound while caring for dogs and cats with naturally occurring tumors.
Purdue cancer clinical trials →
Who the current listings are forDogs
Cancer types currently listedHepatocellular Carcinoma, Lymphoma, Osteosarcoma, Urothelial Carcinoma
Where visits take placePurdue University Veterinary Hospital, 625 Harrison St, West Lafayette, IN 47907
Current options at Purdue University College of Veterinary Medicine
Open an option to see who may qualify, locations, costs or coverage, contact details and the official source.
cPD-L1 immunotherapy with vinblastine and deracoxib for canine invasive urothelial carcinoma
Purdue University Veterinary Hospital / Werling Comparative Oncology Research Center · USA
Actively recruiting
What is being offered: cPD-L1 monoclonal antibody, vinblastine and deracoxib in one of three treatment sequences; all dogs receive all three drugs
Who may qualify: Active tumor required; Serum creatinine lte 2; Planned chemo
May not qualify if: Librela; Cytopoint; Current supplements
Costs / coverage: 🟡 Partially funded. Owners pay $300 per Purdue study visit; the study covers the remaining Purdue costs for cancer treatment, response monitoring and management of potential treatment side effects.
Contact: Lindsey Fourez, Purdue clinical trials technician — lfourez@purdue.edu; 765-494-1130
Location
- Purdue University Veterinary Hospital, 625 Harrison St, West Lafayette, IN 47907
Official study / enrollment information →
HIFU tumor ablation followed by CHOP for canine multicentric lymphoma
Purdue University Veterinary Hospital — Werling Comparative Oncology Research Center · USA
Currently enrolling
What is being offered: Partial HIFU ablation of one lymph node followed by standard UW-25 CHOP chemotherapy
Who may qualify: Confirmed cancer diagnosis required; Active tumor required; Min age years: 1; Untreated newly diagnosed; Intermediate or large cell multicentric lymphoma; Planned chop; Min weight kg exclusive: 8
May not qualify if: Small cell lymphoma; Stage v lymphoma; Extranodal lymphoma; Recent chemotherapy 3w; Recent steroids 2w; Significant liver or kidney dysfunction; Relapsed lymphoma
Costs / coverage: 🟡 Partially funded — HIFU, sedation/anesthesia, study biopsies and laboratory work are covered; the study provides a $2,000 CHOP credit and up to $2,000 additional support for HIFU-related adverse effects or CHOP. Initial diagnostics and unrelated care remain owner-paid.
Contact: Purdue Tumor Ablation Lab — TumorAblation@purdue.edu; referral required through Purdue Veterinary Hospital
Location
- Purdue University Veterinary Hospital, 625 Harrison St, West Lafayette, IN 47907
Official study / enrollment information →
H-FIRE tumor ablation before surgery for canine liver cancer
Purdue University Veterinary Hospital — Werling Comparative Oncology Research Center · USA
Currently enrolling
What is being offered: High-frequency irreversible electroporation (H-FIRE) followed 5–7 days later by surgical liver-tumor resection
Who may qualify: Confirmed cancer diagnosis required; Active tumor required; Liver tumor; Resectable; Planned surgical resection; Anesthesia candidate
May not qualify if: Coagulation disorder; Severe systemic illness; Owner declines post hfire surgery
Costs / coverage: 🟡 Partially funded — H-FIRE, post-treatment CT and study rechecks are covered, with a $2,000 credit toward surgical resection. Owners pay remaining surgery costs, complications unrelated to H-FIRE and unrelated care.
Contact: Purdue Tumor Ablation Lab — TumorAblation@purdue.edu; Purdue Veterinary Hospital Referrals — 765-494-1107
Location
- Purdue University Veterinary Hospital, 625 Harrison St, West Lafayette, IN 47907
Official study / enrollment information →
HIFU tumor ablation before amputation and carboplatin for canine osteosarcoma
Purdue University Veterinary Hospital — Werling Comparative Oncology Research Center · USA
Currently enrolling
What is being offered: Partial HIFU ablation followed by limb amputation and adjuvant carboplatin chemotherapy
Who may qualify: Confirmed cancer diagnosis required; Active tumor required; Min age years: 1; Appendicular osteosarcoma; No metastasis; Suitable hifu acoustic window; Planned amputation; Planned carboplatin; Min weight kg exclusive: 8
May not qualify if: Metastatic; Recent chemotherapy 3w; Recent steroids 2w; Poor performance status
Costs / coverage: 🟡 Partially funded — HIFU and functional imaging are covered, up to $2,600 is provided toward amputation, and chemotherapy recheck visits are covered. Owners pay initial staging, remaining surgery costs, carboplatin administration and surgery-related complications.
Contact: Purdue Tumor Ablation Lab — TumorAblation@purdue.edu; Purdue Veterinary Hospital Referrals — 765-494-1107
Location
- Purdue University Veterinary Hospital, 625 Harrison St, West Lafayette, IN 47907
Official study / enrollment information →
Before you contact the center
A listing here does not mean every pet will qualify. Enrollment can change, and the study team makes the final decision after reviewing your pet’s diagnosis, records and previous treatment.
Have the pathology report, recent imaging and treatment history ready. Ask whether a referral is required, which visits must happen in person and what the study pays for before making travel plans.
Check all options for your pet →
Free to use. No registration or paid report.
